Tauriga Sciences Inc. Completes $5 Million Stock Purchase Agreement With New York Based Institutional Investor Magna Group Through Flagship Equity Enhancement Program

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, June 5, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) (“Tauriga” or “the Company”), a diversified life sciences company focused on investing in proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare, is pleased to announce that the Company has entered into a common stock purchase agreement for a $5 million Equity Enhancement Program with a Magna Group affiliate fund, Hanover Holdings I, LLC (the “Investor”), headquartered in New York, NY. The program will enable Tauriga Sciences to capitalize on important business opportunities that will increase shareholder value.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC